1) lapatinib ditosylate
拉帕替尼二甲苯磺酸酯
2) lapatinib
拉帕替尼
1.
The Therapeutic Effect Evaluation of Lapatinib Plus Capecitabine for HER2 Positive Advanced Breast Cancer;
拉帕替尼联合卡培他滨治疗HER2过表达晚期乳腺癌的疗效评价
2.
Lapatinib in Combination with Bortezomib Inhibits Breast Cancer Cells Growth and the Activity of Bortezomib to Lapatinib-resistant Breast Cancer Cell
拉帕替尼联合硼替佐米抑制乳腺癌细胞生长及硼替佐米对拉帕替尼耐药细胞的活性的研究
3) imatinib mesylate
甲磺酸伊马替尼
1.
Effects of Imatinib Mesylate in Patients with Chronic Myeloid Leukemia;
甲磺酸伊马替尼治疗慢性粒细胞白血病的循征评价
2.
Hydropericardium due to imatinib mesylate;
甲磺酸伊马替尼胶囊引起心包积液
3.
Adverse effects and precautions of imatinib mesylate;
甲磺酸伊马替尼的不良反应及预防处理
4) Imatinib
甲磺酸伊马替尼
1.
Curative effect of imatinib in the treatment of unresectable/recurrent/metastatic gastrointestinal stromal tumor;
甲磺酸伊马替尼治疗手术后复发和/或转移的胃肠道间质瘤的疗效分析
2.
Clinical Efficacy of Imatinib Meylate in Treatment of Patients with Chronic Myeloid Leukemia in Advanced Phase;
甲磺酸伊马替尼治疗进展期慢性粒细胞白血病的临床疗效观察
3.
Conclusion Imatinib induced high rate of cytogenetic and hematologic responses in patients with chronic myeloid leukemia, and the adverse effects were mild.
目的评价甲磺酸伊马替尼治疗慢性粒细胞白血病(CML)临床疗效,及其安全性。
5) flumatinib mesylate
甲磺酸氟马替尼
1.
AIM:To identify primary metabolites of flumatinib mesylate in chronic myelocytic leukemia patients.
目的:研究酪氨酸激酶抑制剂抗肿瘤新药甲磺酸氟马替尼在慢性粒细胞白血病人体内的主要代谢产物。
6) 2-bis(p-tolylsulfonato)ethane
二对甲苯磺酸乙二醇酯
1.
Synthesis and characterization of 1,2-bis(p-tolylsulfonato)ethane;
二对甲苯磺酸乙二醇酯的合成与表征
补充资料：2,4-二甲苯磺酸
分子式：C8H10O3S
分子量：186.23
CAS号：25321-41-9
性质：
分子量：186.23
CAS号：25321-41-9
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条